A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Rofecoxib in Decreasing the Risk of Prostate Cancer (VIP Study)

  • Barve, Ashutosh (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/03 → 1/31/08